==Welcome To The Coelyn Group==

Ronald H. Coelyn
Founding Managing Partner

Ron is the Founding Partner of The Coelyn Group which specializes in Healthcare and Life Sciences. For the past 17 of his 30-year career, he has been active in these industries as a senior executive officer and, most recently, as an executive search consultant (both as a Founder of this Firm and as a Partner in the prestigious international executive search firm SpencerStuart). His executive search consulting practice spans engagements ranging from Chairman of The Board, Members of The Board of Directors, President & Chief Executive Officer to a variety of Vice Presidential and other senior level executive positions.

Ron was previously the President & Chief Operating Officer of a medical diagnostics company (therapeutic drug monitoring and instruments) responsible for sales and marketing, research and development, regulatory and clinical affairs, quality systems, manufacturing, finance, etc. He arranged several Private Placement investment transactions to fund scientific discovery and development, successfully took the company public in an Initial Public Offering (IPO) of equity securities, and later sold the company to a large multinational Life Sciences firm.

Concurrently, Ron also co-founded two biotechnology companies, both of which went public after the completion of equity financing and were later acquired by larger firms.

He was also Chairman, President & Chief Executive Officer, and a majority shareholder of a healthcare information systems company focused on practice management and electronic medical records for physician and dental group practices, small hospitals, clinics, surgical centers and other alternate care delivery sites. The company grew rapidly under his leadership and he was instrumental in its subsequent acquisition by a large computer hardware manufacturer and value-added-reseller (VAR).

Previously, he was a senior executive officer for a Fortune 100 financial services company that grew from $100 million to more than $1.4 billion in annual revenues over a six-year period. For several years he was responsible for the company’s international business operations headquartered in London, England. He was also a Vice President, Corporate Finance for a prestigious regional investment-banking firm.

During his career, Ron has completed more than 40 mergers and acquisitions, numerous private placements, foreign currency swaps, income tax treaty arbitrage transactions, strategic partnerships and IPO's. He has also been a corporate director, shareholder and founder of companies involved with pharmaceutical research and development (cancer research, monoclonal antibodies, etc), medical device instrumentation (analytical instrumentation), and medical in vitro diagnostics (automated chromosome analysis).

Ron was previously Co-Chairman of LINC (Life Sciences Industry Council) (now The Southern California Biomedical Council (SoCalBio) of Orange County, California; a member of the Bio Medical Industry Council's Board of Directors; an Advisory Board Member of the American Heart Association (Irvine, California); and an associate member of AdvaMed, previously the Health Industry Manufacturer's Association (HIMA); a Member of the Board of Intellectual Capital of Gerbsman Partners, LLC., a specialty investment bank and turn-around/crisis management firm; a frequent speaker at the Capital Roundtable; and until recently, a Corporate Director/Member of The Board of Directors and Chairman of the Compensation Committee of Endologix, Inc., a publicly-traded medical device company.

Lynn S. Nishimoto
Founding Partner

Lynn is a Co-Founding Partner of The Coelyn Group and Managing Director of Recruitment. For the past 12-years, she has led executive search engagements in several Life Science industry sectors including medical devices, biotechnology, pharmaceuticals, medical diagnostics, and healthcare provider services. Possessing engaging intellectual incisiveness and piercing intelligence, her projects range from Corporate Directors to Presidents & Chief Executive Officers, to Chief Scientific Officers and Vice Presidents of various disciplines such as sales, marketing, finance, clinical and regulatory affairs and quality systems.

Previously, Lynn held various engineering management and regulatory positions with large, international corporations and several entrepreneurial high-tech/biotechnology firms. She was responsible for contract negotiation and managed the completion of complex multi-million dollar projects. She also managed regulatory compliance, including periodic regulatory and quality system audits by several governmental agencies. Several years later, she was recruited by a prestigious boutique executive search consultancy firm that specialized in the recruitment of senior level executives in the engineering and bioengineering space.

In 1990, Lynn was the Founder and Managing Director of a successful business consulting practice focused on strategic planning, capital formation and corporate partnerships with early and developing stage high-tech and biotech companies. In 1992, she decided to return to the executive search profession and co-founded The Coelyn Group. She was a member of LINC (LifeSciences Industry Council) (now The Southern California Biomedical Council (SoCalBio) of Orange County, California.

Michael P. Oliver
Managing Director

Mike is Managing Director, Life Sciences of The Coelyn Group. He leads the West Coast practice for executive search engagements in the Life Science industry sectors, including medical devices, biotechnology, pharmaceuticals, medical diagnostics, and other medical-related technologies. His executive search consulting practice spans engagements from Chairman of the Board, Board Directors, Chief Executive Officers and Presidents as well as Vice Presidential, Director and other senior management positions.

Previously, Mike held senior sales, marketing and general management positions for a variety of medical device, diagnostic, service, equipment and software companies. For 10 years Mike was President, Chief Executive Officer and Corporate Director of a publicly-traded medical device company operating in the cancer diagnostic and treatment space. He has served several medical service and technology companies as Chief Operating Officer and Vice President of Sales & Marketing with both domestic and international responsibilities. He has worked in medical diagnostics, distribution, capital equipment, instruments, software, and services companies. He and the sales teams he has managed have sold products into virtually every department of the hospital, as well as products and services to healthcare payers. He was part of four separate management teams that took struggling medical technology companies, dramatically improved their operating results and successfully sold the companies to strategic purchasers. Mike also spent a number of years consulting with Fortune 500 companies in the medical and technology spaces regarding operational improvement, increasing sales penetration, new product development and advising on opportunities in the M&A space.

Mike has served the Life Sciences community in San Diego for 5 years as the Co-Chair of the Medical Device Committee of Biocom. He also participated in the planning committee for Biocom’s annual DeviceFest meeting.